Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Hepatitis C (HCV) Genotype 2 Clinical Research Samples

Discovery Life Sciences provides the highest quality Hepatitis C (HCV) Genotype 2 Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Hepatitis C (HCV) Genotype 2 Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 25 of 25 total samples
 (0)
Checkout
Advanced Data View:
Showing 25 of 25 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Detail 1Test 2Test Data 2Detail 2Test 3Test Data 3Product
Details
Price
Buy
Blood TypeSymptoms3-series HepB VaccineIs Subject on Anti-Viral Therapy / TreatmentAcquired Infection CategoryAdditional TestingHepatitis SerologyCo-Infections
BBS0000-CV900106431041014DDHepatitis C (HCV) Genotype 2Vietnam1.0013.00$200.0070 YMale< -70C10-Apr-14Roche cobas1,600,000 cps/mLLightpower HCV Genotype Rt-PCR2$200.00UnknownDecreased appetite; Fatigue; Abdominal pain; Jaundice; DepressionNoNoUnknownALT: 110; AST: 68; Bilirubin: 67.3 umol/L; Serum Creatinine: 0.9 mg/dL; HCV 2009
BBS0000-CV900106441060614DDHepatitis C (HCV) Genotype 2Vietnam1.008.00$200.0033 YMale< -70C06-Jun-14Roche cobas11,100,000 copies/mLLightpower HCV Genotype Rt-PCR2$200.00UnknownNo symptomsNoYes
Tenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mg
Sexual TransmissionALT: 143; AST: 97; LDH: 203; Bilirubin: 9.8 umol/LHBsAg-; Anti HCV+ (Elisa)HIV+
2013
BBS0000-EN900107444120117DDHepatitis C (HCV) Genotype 2Italy1.002.00$200.0066 YMale<-70C01-Dec-17Roche cobas16,400,000 IU/mL28-Sep-17Siemens TruGene HCV 5NC2a28-Sep-17HCV Date of Diagnosis7-Apr-10$200.00UnknownNo symptomsNoNoU/AALT: 38 U/L | AST: 38 U/L | ALP: 60 U/L | Bilirubin: 0.4 mg/dL | Serum Creatinine: 0.6 mg/dL | Chronic Hepatitis C
28-Sep-17
HBsAg-, HBsAb-, HBcAb-, HBeAg-,
28-Sep-17
None
BBS0005-AA900061191101512DDHepatitis C (HCV) Genotype 2Russia0.5 mL Serum1.002.00$200.0026 YFemaleUnknown< -70C15-Oct-12Abbott Realtime PCR480,000 IU/mL5-Oct-12Abbott Real Time PCR2b5-Oct-12$200.00UnknownDecreased appetite, Fatigue, DepressionYesNoUnknownALT: 698; AST: 256; ALP: 112; Bilirubin: 19.0; Serum Creatinine 0.068 mg/dL
5-Oct-12
anti HCV (G)+ (Abbott)
5-Oct-12
BBS0005-CJ900023221121312DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.002.00$200.0059 YMaleNon-Hispanic<-70°C13-Dec-12Abbott Realtime PCR168,883 IU/mLSiemens TruGene HCV2$200.00UnknownJoint painNoNoDental CareALT: 45; AST: 54; ALP: 87; LDH: 470; Bilirubin: 1.96; Serum Creatinine: 0.7 mg/dL; Hepatocellular carcinomaanti HCV+ (Abbott)
BBS0005-CJ900023222020413DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.001.00$200.0058 YFemaleNon-Hispanic<-70°C04-Feb-13Abbott Realtime PCR1,152,951 U/mLSiemens TruGene HCV2$200.00UnknownFatigue; Abdominal painNoNoTransfusionALT: 659; AST: 283; ALP: 56; LDH: 388; Bilirubin: 0.86; Serum Creatinine: 0.62 mg/dL; Chronic Hepatitisanti HCV+ (Abbott)
BBS0005-CJ900053341051013DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.001.00$200.0054 YFemaleNon-Hispanic<-70°C10-May-13Abbott Realtime PCR499,000 U/mLSiemens TruGene HCV2a/2c$200.00UnknownSleep disturbancesNoNoDental Care; Household ContactALT: 19; AST: 24; Chronic Hepatitisanti HCV+ (Abbott)
BBS0005-CJ900061281072613DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.002.00$200.0077 YMaleNon-Hispanic<-70°C26-Jul-13Abbott Realtime PCR224 U/mLSiemens TruGene HCV2a/2c$200.00UnknownFatigue; JaundiceNoNoSurgeryALT: 45; AST: 65; Chronic Hepatitisanti HCV+ (Abbott)
BBS0005-CV900041872041114DDHepatitis C (HCV) Genotype 2Vietnam0.5 mL Serum1.0013.00$200.0056 YMaleNon-Hispanic< -70C11-Apr-14Roche cobas5,320,000 copies/mLLightpower HCV Genotype Rt-PCR2$200.00UnknownDecreased appetite; Fatigue; Abdominal pain; Jaundice; Sleep disturbancesNoNoUnknownALT: 40; AST: 17; ALP: 78; Bilirubin: 100 umol/L; Serum Creatinine: 1.1 mg/dL
BBS0005-CV900047640091614DDHepatitis C (HCV) Genotype 2Vietnam0.5 mL Serum1.004.00$200.0065 YMaleNon-Hispanic< -70C16-Sep-14Roche cobas84,600 IU/mL5-Sep-14Lightpower HCV Genotype Rt-PCR213-Oct-14$200.00UnknownDecreased appetite; FatigueNoNoUnknownALT: 459; AST: 1579; Bilirubin: 46.8 umol/L; Serum Creatinine: 0.8 mg/dL
3-Sep-14
Anti HCV + (Cobas)
28-Aug-14
BBS0005-CV900056189101016DDHepatitis C (HCV) Genotype 2Vietnam0.5 mL Serum1.003.00$200.0052 YMaleNon-Hispanic<-70C10-Oct-16Roche cobas5,030,000 IU/mL6-Oct-16Lightpower HCV Genotype Rt-PCR212-Oct-16$200.00UnknownFatigue; Abdominal painNoNoUnknownALT: 67 U/L; AST: 74 U/L; Bilirubin: 8.2 umol/L; Serum Creatinine: 86 umol/L
5-Oct-16
Anti HCV + (cobas 6000E and Architect)
6-Sep-16
N/A
BBS0005-CV900069480032114DDHepatitis C (HCV) Genotype 2Vietnam0.5 mL Serum1.006.00$200.0055 YFemaleNon-Hispanic< -70C21-Mar-14Roche cobas31,000 copies/mLLightpower HCV Genotype Rt-PCR2$200.00UnknownDecreased appetite; Fatigue; Joint pain; Sleep disturbancesNoNoUnknownALT: 48; AST: 34; ALP: 74; Bilirubin: 10.2 umol/L; Serum Creatinine: 0.6 mg/dL
BBS0005-EN900019495101317DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.0010.00$200.0060 YFemaleNon-Hispanic<-70C13-Oct-17Roche cobas3,100,000 IU/mL21-Sep-17Siemens TruGene HCV 5NC1b21-Sep-17HCV Date of Diagnosis9-Jun-10$200.00UnknownNo symptomsNoNoU/AALT: 38 U/L | AST: 42 U/L | | Bilirubin: 1.35 mg/dL | Serum Creatinine: 0.26 mg/dL | Chronic Hepatitis C
5-Sep-17
HBsAg-, HBsAb+, HBcAb-,
5-Sep-17
None
BBS0005-EN900023466051618DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.003.00$200.0055 YMaleNon-Hispanic<-70C16-May-18Roche cobas9,560,000 IU/mLHCV Viral LoadGenotype2a/2c10-Oct-143-series HepB VaccineNo$200.00UnknownNo symptomsNoU/ABilirubin: 1.3 mg/dL | Creatinine: 1.0 mg/dL | Chronic Hepatitis C
11-May-18
HBsAg- | HBsAb- | HBcAb- | (CMIA)
11-May-18
None
BBS0005-EN900023467061218DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.006.00$200.0073 YMaleNon-Hispanic<-70C12-Jun-18Roche cobas8,900 IU/mLHCV Viral LoadGenotype2a/2c10-Oct-173-series HepB VaccineNo$200.00UnknownNo symptomsNoTransfusionBilirubin: 0.63 mg/dL | Creatinine: 1.29 mg/dL | Chronic Hepatitis C
8-Mar-18
HBsAg- | HBsAb- | HBcAb- | (CMIA)
10-Oct-17
None
BBS0005-EN900023469062218DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.0010.00$200.0076 YFemaleNon-Hispanic<-70C22-Jun-18Roche cobas627,000 IU/mLHCV Viral LoadGenotype28-Jul-053-series HepB VaccineNo$200.00UnknownNo symptomsNoU/ABilirubin: 0.5 mg/dL | Creatinine: 0.9 mg/dL | Chronic Hepatitis C
9-Jul-18
HBsAg- | HBsAb- | HBcAb- | (CMIA)
18-May-18
None
BBS0005-EN900026484070418DDHepatitis C (HCV) Genotype 2Italy1.001.00$200.0068 YFemale<-70C04-Jul-18Roche cobas9,300,000 IU/mLHCV Viral LoadGenotype24-Jul-183-series HepB VaccineNo$200.00UnknownNo symptomsNoU/ABilirubin: 0.6 mg/dL | Creatinine: 1.2 mg/dL | Chronic Hepatitis C
6-Jul-18
HBsAg- | HBsAb- | HBcAb- | (CMIA)
12-Feb-18
None
BBS0005-EN900031760072613DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.001.00$200.0060 YMaleNon-Hispanic< -70C26-Jul-13Abbott RealTime PCR1,150,000 U/mLSiemens TruGene HCV2$200.00UnknownFatigueNoNoDental CareALT: 135; AST: 114; ALP: 335; Bilirubin: 0.79; Serum Creatinine: 0.75 mg/dL; Chronic Hepatitisanti HCV+
2009
BBS0005-EN900032640101817DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.001.00$200.0069 YMaleNon-Hispanic<-70C18-Oct-17Roche cobas8,280,000 IU/mL15-Feb-17Siemens TruGene HCV 5NC2b10-Oct-16HCV Date of Diagnosis4-Mar-16$200.00UnknownFatigueNoNoU/AALT: 38 U/L | AST: 38 U/L | Bilirubin: 0.6 mg/dL | Serum Creatinine: 1.1 mg/dL | Chronic Hepatitis C
26-May-17
HBsAg-, HBsAb+, HBcAb-,
25-May-17
None
BBS0005-EN900071944092817DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.002.00$200.0079 YFemaleNon-Hispanic<-70C28-Sep-17Roche cobas10,900,000 IU/mL28-Oct-16Siemens TruGene HCV 5NC2a8-May-17HCV Date of Diagnosis28-Oct-16$200.00UnknownFatigueNoNoU/AALT: 40 U/L | AST: 40 U/L | Bilirubin: 0.5 mg/dL | Serum Creatinine: 1.0 mg/dL | Chronic Hepatitis C
11-Oct-17
HBsAg-, HBsAb+, HBcAb+,
6-May-17
None
BBS0005-EN900072650012318DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.002.00$200.0080 YMaleNon-Hispanic<-70C23-Jan-18Roche cobas2,790,000 IU/mLHCV Viral LoadGenotype2a14-Nov-173-series HepB VaccineNo$200.00UnknownFatigueNoU/AALT: 320 U/L | AST: 268 U/L | Chronic Hepatitis C
16-Oct-17
HBsAg- | HBsAb- | HBcAb- | HBeAg- | HBeAb- (CMIA)
16-Oct-17
None
BBS0005-EN900072657012318DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.002.00$200.0049 YFemaleNon-Hispanic<-70C23-Jan-18Roche cobas5,430,000 IU/mLHCV Viral LoadGenotype2a11-Nov-153-series HepB VaccineNo$200.00UnknownNo symptomsNoU/AALT: 120 U/L | AST: 70 U/L | Bilirubin: 0.4 mg/dL | Creatinine: 0.5 mg/dL | Chronic Hepatitis C
22-Sep-17
HBsAg- | HBsAb- | HBcAb- | (CMIA)
25-Oct-17
None
BBS0005-EN900072659112717DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.001.00$200.0076 YFemaleNon-Hispanic<-70C27-Nov-17Roche cobas21,300,000 IU/mL12-Sep-17Siemens TruGene HCV 5NC2a12-Sep-17HCV Date of Diagnosis5-Apr-17$200.00UnknownNo symptomsNoNoU/AALT: 36 U/L | AST: 35 U/L | Bilirubin: 0.4 mg/dL | Serum Creatinine: 0.7 mg/dL | Chronic Hepatitis C
12-Sep-17
HBsAg-, HBsAb+, HBcAb-,
4-Dec-17
None
BBS0005-EN900072661020918DDHepatitis C (HCV) Genotype 2Italy0.5 mL Serum1.007.00$200.0070 YMaleNon-Hispanic<-70C09-Feb-18Roche cobas16700000 IU/mLHCV Viral LoadGenotype210-Nov-153-series HepB VaccineNo$200.00UnknownFatigueNoU/ALDH: 161 U/L | Bilirubin: 0.4 mg/dL | Creatinine: 1.34 mg/dL | Chronic Hepatitis C
12-Feb-18
HBsAg- | HBsAb- | HBcAb+ | (CMIA)
12-Feb-18
None
BBS0005-FI900061282012513DDHepatitis C (HCV) Genotype 2USA0.5 mL Serum1.003.00$200.0057 YMaleNon-Hispanic<-70°C25-Jan-13Roche cobas2,994,740 IU/mLInnogenetics Versant HCV2$200.00UnknownFatigueYesNoIV Drug AbuseALT: 155; AST: 189; ALP: 125; Bilirubin: 1.7; Serum Creatinine: 0.72 mg/dLHep A Total Ab-; Hep BsAg-; Hep Bc Total Ab+

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.